| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4238801 | Journal of Vascular and Interventional Radiology | 2012 | 9 Pages |
Abstract
Same-day discharge after superselective DEB transarterial chemoembolization for unresectable HCC is safe and feasible. BCLC C or D stage of disease, a higher Charlson comorbidity score, and groin or closure device complications are correlated with a greater likelihood for overnight admission.
Keywords
PVTPESNCI CTCAEDEBECoGBCLCHCCTransarterial embolizationstandard deviationportal vein thrombosisTAEdrug-eluting beadpostembolization syndromeeastern cooperative oncology groupadverse eventNational Cancer Institute Common Terminology Criteria for Adverse EventsPerformance statusHepatocellular carcinomaBarcelona Clinic Liver CancerClip
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Hasmukh J. MD, Shoaib MBBS, Bassel F. MD, John S. MD, David A. MD, Hyun S. MD,